Micro-albuminuria and glomerular hyperfiltration are primary indicators of renal dysfunctions in Sickle Cell Disease (SCD), with more severe manifestations previously associated with variants in APOL1 and HMOX1 among African Americans. We have investigated 413 SCD patients from Cameroon. Anthropometric variables, haematological indices, crude albuminuria, albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) were measured. Patients were genotyped for 3Á7 kb alpha-globin gene (HBA1/HBA2) deletion, and for variants in APOL1 (G1/G2; rs60910145, rs73885319, rs71785313) and HMOX1 (rs3074372, rs743811). The median age was 15 years; the majority presented with micro-albuminuria (60Á9%; n = 248), and approximately half with glomerular hyperfiltration (49Á5%; n = 200). Age, male sex, haemoglobin level, leucocyte count, mean corpuscular volume, blood pressure, body mass index and creatinine levels significantly affected albuminuria and/or eGFR. Co-inheritance of alpha-thalassaemia was protective against macro-albuminuria (P = 0Á03). APOL1 G1/G2 risk variants were significantly associated with the ACR (P = 0Á01) and borderline with eGFR (P = 0Á07). HMOX1 -rs743811 was borderline associated with micro-albuminuria (P = 0Á07) and macro-albuminuria (P = 0Á06). The results revealed a high proportion of micro-albuminuria and glomerular hyperfiltration among Cameroonian SCD patients, and support the possible use of targeted genetic biomarkers for risks assessment.
Sickle Cell Disease (SCD) is a monogenic haemoglobinopathy caused by mutation in the b-globin subunit of adult haemoglobin (HbA). An estimated 300 000 SCD-affected births occurs annually, with three quarters of these recorded in sub-Saharan Africa (Piel et al, 2013) . Sickle cell disease patients are susceptible to vaso-occlusion, with the disease characterized by recurrent episodes of ischaemia-reperfusion injury and haemolytic anaemia, cumulatively contributing to progressive end organ damage Bartolucci & Galacteros, 2012) . The kidney is a particularly susceptible organ, with sickle cell nephropathy (SCN) occurring in 5-18% of patients, conferring increased risk of mortality (Platt et al, 1994; McClellan et al, 2012) . Glomerular enlargement is probably the earliest renal abnormality in SCD (Ware et al, 2010) , with paediatric patients displaying increased glomerular filtration rate (GFR) and proteinuria (Wigfall et al, 2000; Ware et al, 2010) . Micro-albuminuria is the most sensitive early clinical marker of kidney dysfunction (Guasch et al, 1997 (Guasch et al, , 1996 , preceding the development of end stage kidney disease (ESKD) in paediatric and adult patients (Guasch et al, 1999 (Guasch et al, , 2006 Becton et al, 2010) .
The co-inheritance of genetic factors, specifically alphathalassaemia and specific variants in the fetal haemoglobin (HbF) promoting loci, have been proven to delay the clinical progression of kidney disease in SCD patients (Steinberg et al, 2003; Saraf et al, 2017) . The co-inheritance of the 3Á7 kb alpha-thalassaemia deletion and SCD is more specifically associated with a lower prevalence of macro-albuminuria (Guasch et al, 1999; Nebor et al, 2010; Lamarre et al, 2014) . In addition, two coding variants of APOL1, G1 (rs73885319, p. Ser358Gly and rs60910145, p.Ile400Met) and G2 (rs71785313, p.Asn404_Tyr405del), have been previously associated with chronic kidney disease (CKD) and focal segmental glomerulosclerosis (FSGS) in African Americans (Genovese et al, 2010; Tzur et al, 2010; Kopp et al, 2011) . APOL1 encodes the trypanolytic factor responsible for lysis of Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense, the pathogens that cause human African trypanosomiasis. Moreover, HMOX1 forms the rate-limiting step in the catabolism of free haem (Tenhunen et al, 1968) , with two promoter polymorphisms, a GT-dinucleotide repeat (rs3074372) and a single nucleotide polymorphism (SNP) (rs743811), associated with CKD (Bean et al, 2012; Saraf et al, 2015) . Genetic variations in both APOL1 and HMOX1 have been associated with SCD nephropathy among adult African Americans (Ashley-Koch et al, 2011; Saraf et al, 2015; Schaefer et al, 2016) . The study of associations between these genomic variants and the development of micro-albuminuria has not yet been reported in SCD populations in Africa.
Cameroon is a sub-Saharan African Country that has a population of approximately 20 million, with a SCD carrier frequency range of 8-34% (Weatherall & Clegg, 2001 ). The Cameroon national control programme for SCD has remained a policy document without implementation; there is not yet provision of universal newborn screening, and the median age of SCD diagnosis is 3Á3 years, with no development of specialized centres for lifelong medical treatment resulting in very few patients being exposed to hydroxycarbamide (also termed hydroxyurea) treatment (Wonkam et al, 2014a) . Moreover, there is no universal medical insurance coverage in Cameroon, and care of SCD patients is therefore dependent on financial support and care giving by family members. However, poverty in Cameroon affects more than 50% of the rural population and up to 30% of the urban population (World Bank, 2010) , which in turn means that the financial burden of the necessary medical care for SCD often cannot be met (Wonkam et al, 2014a) and patients frequently suffer exceptionally severe SCD sequelae, such as stroke (Njamnshi et al, 2006) and neurocognitive dysfunctions (Ruffieux et al, 2013) .
In this study, we aim to investigate the prevalence of micro-albuminuria and glomerular hyperfiltration in a Cameroonian SCD cohort, and to determine the clinical, biological and genetic predictors of albuminuria and estimated glomerular filtration rate (eGFR). 
Methods

Ethical approval
Study participants
A total of 413 individuals living with sickle anaemia (HbSS) from Cameroon were prospectively investigated. Patients were recruited at the Yaound e Central Hospital and Laquintinie Hospital in Douala, Cameroon between January 2010 and December 2011. Routine blood counts of patients and haemoglobin (Hb) electrophoresis were conducted on arrival at the hospital, initially using the alkali denaturation test (ADT) in 55Á5% of the cohort, and subsequently high performance liquid chromatography (HPLC), when it became available (Wonkam et al, 2014a) . Socio-demographic (age, gender) , anthropometric (height, weight, body mass index [BMI]), systolic and diastolic blood pressures, clinical variables and haematological indices were collected for these patients.
Measurements of renal functions
Routine laboratory tests were performed to measure serum creatinine and urine creatinine concentrations. The level of albumin in the urine was determined using either the Siemens Clinitek Statusâ test (Siemens Healthcare GmbH, Erlangen, Germany) or the Hemocue Albumin 20â system (Hemocue, Angelholm, Sweden). Urinary albumin quantitation was performed on first morning void samples during a planned hospital visit, when patients were not experiencing SCD vaso-occlusive crisis. The presence of albumin in the urine was defined as normal (<30 mg/l), micro-albuminuria (30-300 mg/l) or macro-albuminuria (>300 mg/l), while the albumin-to-creatinine ratio (ACR), represented as albumin (mg) per mmol creatinine, was defined as normo-albuminuria (<3 mg/mmol), micro-albuminuria (3-30 mg/mmol) or macro-albuminuria (>30 mg/mmol).
The GFR was estimated (eGFR) using three equations: (i) The Modification of Diet in Renal Disease (MDRD) (Levey et al, 1999) , (ii) Cockcroft-Gault (Cockcroft & Gault, 1976) , and (iii) the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) (Levey et al, 2009 ) equation. The proportion of patients with glomerular hyperfiltration (>130 ml/ min/1Á73 m 2 for women, and >140 ml/min/1Á73 m 2 for men) (Haymann et al, 2010; Vazquez et al, 2014) was also investigated. The CKD-EPI equation has previously been identified as the most precise equation displaying the least bias in adult SCD patients (Arlet et al, 2012; Asnani et al, 2013) , and will therefore be used for illustration in the main text of the present article, but comparative values of factors affecting eGFR using the two other equations are presented as in Table S1 .
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Molecular methods
Sickle cell anaemia mutation, b-globin gene (HBB) cluster haplotypes, and 3Á7 kb a-globin gene (HBA1/HBA2) deletion. DNA was extracted from peripheral blood following the manufacturer's instructions (Puregene Blood Kit; Qiagen, Hilden, Germany). Molecular analysis to determine the presence of the sickle mutation was carried out on 200 ng DNA by polymerase chain reaction (PCR) to amplify a 770 bp segment of HBB, followed by DdeI restriction analysis of the PCR product (Saiki et al, 1985) . Using published primers and methods, five restriction fragment length polymorphism (RFLP) sites in the HBB cluster were amplified to analyse the XmnI (5 0G c), HindIII ( G c),
HindIII (
A c), HincII (3 0 (b) and HinfI (5 0 b) for the HBB haplotype background (Bitoungui et al, 2015) . Using expand-long template PCR (Roche Diagnostics, Basel, Switzerland), the 3Á7 kb HBA1/HBA2 deletion was successfully screened following a previously reported protocol (Rumaney et al, 2014) .
Targeted SNPs in APOL1 and HMOX1 genes. SNP genotyping of rs60910145 (APOL1), rs73885319 (APOL1) and rs743811 (HMOX1) was performed using predesigned TaqMan genotyping assays (Applied Biosystems, Foster City, CA, USA). The PCR protocols were performed on the Bio-Rad CFX96 real time PCR system (Bio-Rad Laboratories, Hercules, CA, USA). The rs3074372 (HMOX1) and rs71785313 (APOL1) variants were genotyped using fragment analysis, incorporating fluorescently labelled forward primers. The HMOX1 repeats were classified as short (≤25 repeats) or long (>25 repeats) (Saraf et al, 2015) . PCR protocols were performed on the Bio-Rad thermal cycler T100 TM , and analysis of the genotype was achieved using the ABI Prism 3130xl Genetic Analyser (Applied Biosystems). Thereafter, Direct Cycle Sequencing using the ABI Prism 3130xl was performed on a subset (10%) of the samples and successfully validated the genotyping results (Figures S1, S2, S3).
Statistical analysis
Descriptive statistical analysis of the prospectively collected patient data was performed using STATA Software version 14Á0Á370 for Windows TM (StataCorp Inc., College Station, TX, USA). Moreover, this software was utilized to investigate associations between clinical variables. A v 2 test with one degree of freedom was used to perform the Hardy-Weinberg equilibrium (HWE). Only the 3Á7del HBA1/HBA2 genotypes (P = 0Á005) were out of HWE, however this deviation from HWE was expected in view of the strong protective effect of this genetic variant on macro-albuminuria, as displayed in the results. General linear and multinomial regression frameworks, adjusted for age and sex, were performed using the statistical package R (version 3Á03, R Foundation for Statistical Computing, Vienna, Austria) to investigate the relationship between genotype results and clinical data. Genotype results were also compared for the various age groups, stages of clinically defined CKD (Levey et al, 2003) , and between children/adolescents (<18 years old) and adults (≥18 years old). P values <0Á05 were considered statistically significant.
Results
Participants' descriptions
A total of 413 SCD patients were included. Table I summarizes the participants' characteristics. There was roughly equal numbers of males and females (210 and 203, respectively), with a median age of 15 years (25th-75th percentiles: 9-23; minimum-maximum: 2-58) and a lower proportion of adult patients (40%; n = 162). All participants were homozygous HbSS, and the most prevalent HBB cluster haplotypes were Benin (73Á0%, n = 510 chromosomes) and Cameroon (21%, n = 145), with 31Á1% (n = 105) and 10Á4% (n = 25) of patients having co-inherited a single or double 3Á7 kb HBA1/ HBA2 deletion, respectively.
Clinical factors affecting renal functions
The general description of renal functions is summarized in Table I, and Table II summarizes the factors affecting crude albuminuria and eGFR respectively, in Cameroonian SCD patients.
Glomerular filtration estimates.
A total of 404 HbSS individuals had glomerular filtration estimates available. The cohort had a median serum creatinine value of 7 lmol/l (5-8Á5) and eGFR of 135Á1 ml/min/1Á73 m 2 (112-154Á4) ( Table I ).
The CKD-EPI equation indicated that 49Á5% (n = 200) of SCD patients suffered from glomerular hyperfiltration. The eGFR decreased with age (Fig 1; Figure S3A ), as well as the proportion of hyperfiltrating patients per age group (Figure S3B ). Moreover, eGFR was significantly increased in children/adolescents compared to adult SCD patients (P < 0Á0001) ( Figure S3C ; Table S2 ). The eGFR was significantly increased in male patients (P < 0Á0001); and was significantly negatively associated with log transformed systolic and diastolic blood pressure (P < 0Á0001) (Fig 1) . Table S1 displays similar association results with all the equations used to estimate eGFR (MDRD, CKD-EPI and Cockcroft Gault).
Isolated hyperfiltration was present in 34Á2% (n = 67) of patients, while 61Á7% (n = 121) and 4Á1% (n = 8) had hyperfiltration in association with micro-and macro-albuminuria, respectively. The eGFR was not associated with crude albuminuria (P = 0Á87), but with log(ACR) values (r = 0Á022: P = 0Á005) ( Figure S4 ).
Albuminuria. The prevalence of micro-and macro-albuminuria was 60Á9% (n = 248) and 2Á5% (n = 10), respectively.
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The youngest patient with micro-albuminuria was 4 years old. Figure S3C displays the median albuminuria values per age group, indicating a general positive trend between albuminuria and increasing age. Crude albuminuria displayed a near significant association with reduced haemoglobin (r = À0Á09, P = 0Á07), while increased BMI (r = 0Á1, P = 0Á04), leucocyte count (r = 0Á12, P = 0Á02), mean arterial pressure (r = 0Á12, P = 0Á01) and mean corpuscular volume (MCV; r = 0Á17, P = 0Á008) values were positive predictors of increasing albuminuria (Table II; Fig 2) . There was a significant association between albuminuria and increasing age (r = 0Á14, P = 0Á004) (Fig 2; Figure S3D ), and borderline association with decreasing haemoglobin (r = À0Á09, P = 0Á06) (Fig 2) . There was no significant association between patient sex and albuminuria (P = 0Á18), nor between the median values for children/adolescents and adults (Table S2) .
3Á7kb HBA1/HBA2 deletion, APOL1 and HMOX1 and renal function
The 3Á7 kb HBA1/HBA2 deletion was protective against prevalent macro-albuminuria (P = 0Á03). APOL1 G1/G2 showed a statistically significant association with ACR (P = 0Á018), and was borderline with macro-albuminuria (P = 0Á08), and eGFR (P = 0Á07) values, however not with crude albuminuria (Table III; Fig 3) . No significant association was observed between the HMOX1 dinucleotide promoter polymorphism and indicators of renal dysfunction, while the HMOX1 SNP (rs743811) tended to a significant association with crude albuminuria and macro-albuminuria (P = 0Á08 and P = 0Á06, respectively) in a recessive model, but not with log (ACR) values (Table III) . No significant results were observed for the association of genetic variants and clinically defined stages of CKD (Table S3 ). The frequency of the respective genotypes was compared between the various age groups, and no significant differences were found (Table S4) .
Discussion
This study is, to our knowledge, the first to investigate targeted genomic variants and their association with clinical renal phenotypes in a sub-Saharan African cohort. The result indicates that the majority of SCD patients in this sample of Cameroonians presented with micro-albuminuria, as well as a high prevalence of glomerular hyperfiltration. Micro-albuminuria is considered the primary marker of early renal dysfunction (Ataga et al, 2014; Gosmanova et al, 2014) , conferring increased risk of CKD and ESKD development and, ultimately, premature mortality, indicating the need for routine early detection (Asnani & Reid, 2015a,b) . The high prevalence of micro-and macro-albuminuria in our SCD cohort differs with previous occurrence rates of 40% and 19% in adult Americans living with SCD (Haymann et al, 2010), 25Á9% and 16Á5% in Jamaican SCD patients (Asnani et al, 2011) , 28Á2% among SCD children in Uganda (Mawanda et al, 2011) , and 50% combined prevalence rate reported in Nigerian patients (Bolarinwa et al, 2012) . These results could reflect a more severe phenotype in this group of Cameroonian patients living with SCD, as illustrated by a relatively low median Hb level of 74 g/l (Table I) . Decreased haemoglobin is a significant predictor of increased albuminuria (McBurney et al, 2002; Alvarez et al, 2006; Mawanda et al, 2011) . The relative severity and high proportion of micro-albuminuria in this group could be also attributed to the hospital-based recruitment style, as equally high values were observed in a population of hospital-based SCD patients in Saudi-Arabia (AboZenah et al, 2009). The prevalence of glomerular hyperfiltration was comparable to previous studies of patients in French and West Indian cohorts (Haymann et al, 2010; Arlet et al, 2012) , and Congolese HbSS children also displayed a similar prevalence of hyperfiltration (Aloni et al, 2014 (Aloni et al, , 2017 . Among Jamaicans living with SCD, up to half of the hyper-filtrating individuals might also have micro-albuminuria (Asnani & Reid, 2015a , 2015b , further supporting the fact that the state of hyperfiltration is an early pathology in those likely to progress to CKD. Vazquez et al (2014) have similarly described increasing rates of development of microalbuminuria with increasing levels of hyperfiltration.
The present study confirms important clinical predictors of renal dysfunctions. Specifically, our findings replicate the positive association of crude albuminuria with increasing age, reduced haemoglobin and increased BMI (Guasch et al, 2006; Eke et al, 2012; Ranque et al, 2014; Saraf et al, 2014) , while high leucocyte count, high mean arterial pressure and higher MCV values were identified as positive correlates of increasing albuminuria in the present Cameroonian SCD cohort (Table II) . We did not observe a significant association between crude albuminuria and rising blood pressure, as reported previously in Jamaica (Aygun et al, 2011; Asnani et al, 2016) , or between crude albuminuria and hyperfiltration, as observed previously among a French population with African ancestry and African Americans (Thompson et al, 2007; Arlet et al, 2012) . However, these other studies investigated adult patients, while in the present study there is a majority of children and adolescent individuals, and consequently a lower proportion of macro-albuminuria that may explain these differences. Nevertheless, in a subset of the present cohort, we observed a positive relationship between eGFR values and log(ACR) ( Figure S4B ). The surprising positive association of albuminuria and GFR was also recently shown in a prospective longitudinal study (Asnani et al, 2016) . The inconsistent relationship between albuminuria and glomerular filtration remains controversial and deserves further investigation (Barros et al, 2006; Thompson et al, 2007; Mawanda et al, 2011; Arlet et al, 2012) , using prospective studies to unravel the role of albuminuria as a predictor of GFR and the progression of sickle glomerulopathy and worsening CKD in SCD. As found in the present study, elevated haemoglobin, systolic and diastolic blood pressure, BMI, serum creatinine and mean arterial pressure were found to be significant predictors for reduced eGFR (Becker et al, 2014; Asnani et al, 2016) . 
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The 3Á7kb HBA1/HBA2 deletion was co-inherited in 41Á4% (n = 141) of patients, significantly higher than in the previously reported non-SCD individuals (Wonkam et al, 2014b) . As replicated in the present study, and associated with lower MCV, co-inheritance of SCD and a-thalassaemia had protective effects against macro-albuminuria development (Nebor et al, 2010; Day et al, 2012; Lamarre et al, 2014) . Co-inheritance of SCD and a-thalassaemia was associated with reduced clinical severity and, possibly, increased survival rates in a group of Cameroonian patients (Rumaney et al, 2014; Wonkam et al, 2014b) . The lack of association between the targeted genes investigated with clinically defined stages of CKD, as well as the lack of differential frequencies of targeted genetic variants studied among various age groups, child/adolescent and adult patients, are probably due to the small number of homozygote individuals for the minor alleles in the respective sub-groups. These associations require further elucidation through the investigation of a larger cohort of adult patients. The eGFR values were calculated using CKD-EPI. Significant results are indicated using * (P < 0Á05); similar significant results were obtained using MDRD equations and Cockcroft-Gault equations. The horizontal lines that constitute the 'box' correspond to the lower quartile, median and upper quartile parameters. The length of the 'whiskers' that extend from the box in the upwards and downwards direction represent a value of 1Á5 times the interquartile range. Values that lie outside this are considered outliers, or extreme values. (C) Scatter plots illustrating the relationship between eGFR values and BMI. Calculated using the CKD-EPI (r = 0Á529, P < 0Á0001) equation. Similar results were found using MDRD (r = À0Á520, P < 0Á0001) and Cockcroft-Gault (r = À0Á164, P = 0Á018) equations. The BMI (kg/m 2 ) variable is displayed on the x-axis, with the eGFR values on the y-axis. The red line indicates a line of best fit, fitted to the data. (D) Scatter plots illustrating the relationship between eGFR values and logSBP calculated using the CKD-EPI (r = À0Á367, P < 0Á0001) equations. Similar results were found with MDRD (r = À0Á407, P < 0Á0001) and Cockcroft-Gault (P = 0Á018) equations. The log(SBP) variable is displayed on the x-axis, with the eGFR values on the y-axis. The red line indicates a line of best fit, fitted to the data. Similar significant relationship between eGFR values and log(diastolic blood pressure) was also found, calculated using CKD-EPI (r = À0Á296, P < 0Á0001), the MDRD (r = À0Á300, P < 0Á0001) and Cockcroft-Gault (r = À0Á164, P = 0Á001) equations. BMI, body mass index; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration equation; eGFR, estimated glomerular filtration rate; F, female; M, male; SBP, systolic blood pressure; SCD, sickle cell disease. [Colour figure can be viewed at wileyonlinelibrary.com] Previous studies indicated an association of homozygous or compound heterozygous APOL1G1/G2 variants with kidney disease in SCD patients among adult African American (Ashley- Koch et al, 2011; Saraf et al, 2015) , possibly through increased risk of haemoglobinuria (Saraf et al, 2015) . In addition, associations of HMOX1 with ESKD, possibly through reduced protection of the kidney from haemoglobin-mediated toxicity, was also observed (Saraf et al, 2015) . Indeed, intravascular haemolysis is a potential cause of oxidative injury and endothelial damage in SCD (Tracz et al, 2007; Gladwin et al, 2012; Nath & Katusic, 2012) . Exposing human proximal tubular cells to increasing cell-free haemoglobin led Clinical Factors associated with Albuminuria in SCD: Age, and haematological indices. Scatter plot illustrating the positive relationship between age (y-axes) and log crude albuminuria, (r = 0Á142, P = 0Á004) (A), log Leucocyte count (r = 0Á116, P = 0Á0202) (B); MCV (r = 0Á167, P = 0Á008) (C) and a nearly significant negative nature of the relationship with Hb level (r = À0Á091, P = 0Á069) (D). The red lines indicate a line of best fit, fitted to the data. Hb, haemoglobin; MCV, mean corpuscular volume. [Colour figure can be viewed at wileyonlinelibrary.com] P-values obtained from association analysis using the statistical package 'R'. Statistically significant results (P < 0Á05), or results approaching significance (Pffi0Á05) are highlighted in bold, all in recessive model. *In co-dominant model, the association was stronger, P = 0Á009.
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ª 2017 John Wiley & Sons Ltd to increasing concentrations of supernatant kidney injury molecule, reduced viability and induction of HMOX1 (Saraf et al, 2015) . HMOX1 rs743811 was associated with chronic kidney disease stage and longer HMOX1 GT-tandem repeats (>25) were associated with lower eGFR in African Americans (Saraf et al, 2015) . In the present study, the dinucleotide promoter polymorphism showed no significant association with crude albuminuria, macro-albuminuria, increased ACR levels or eGFR for all equations, which may be due to a lack of statistical power due to the young age of our cohort, with relatively low proportion of adults. Moreover, in African American children with SCD, shorter HMOX1 GT repeats were associated with lower rates of hospitalization for acute chest syndrome, consistent with the shorter GT-tandem repeat length polymorphism having a protective effect in SCD (Bean et al, 2012) , and deserves further investigation in Africa. The significant association of variants at APOL1 and nearsignificant association of HMOX1 rs743811 with crude albuminuria or eGFR, both early indicators of renal dysfunction, are novel findings requiring further investigation in more adult Cameroonian SCD patients. In total, the present study indicates that the 3Á7 kb HBA1/HBA2 deletion, HMOX1 and APOL1G1/G2 polymorphisms, in addition to other variants, such as HbF-promoting loci (Saraf et al, 2017) , and variants (calculated using the CKD-EPI equation) values conditioned on the APOL1 G1/G2 polymorphism, based on the presence of zero (n = 333), one (n = 40) or two (n = 5) minor alleles. The horizontal lines that constitute the 'box' correspond to the lower quartile, median and upper quartile parameters. The length of the 'whiskers' that extend from the box in the upwards and downwards direction represent a distance to the maximum and minimum values, respectively. Significant results are indicated using * (P < 0Á05). ACR, albumin/ creatinine ratio; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration equation; eGFR, estimated glomerular filtration rate; SCD, sickle cell disease. [Colour figure can be viewed at wileyonlinelibrary.com] that still need validations (Schaefer et al, 2016) , could lead to early identification of high-risk SCD patients, and contribute to a better screening strategies, leading to targeted preventive and therapeutic interventions.
Possible limitations of the present study are the cross-sectional nature and the hospital based recruitment style that could have selected the sickest SCD patients. Moreover, owing to the young age of the cohort, another possible limitation is the use of the CKD-EPI, Cockcroft-Gault and MDRD equations to estimate the GFR, where the Schwartz formula could have been applied. This formula is postulated to be most accurate in patients younger than 19 years (Schwartz et al, 2009) , however new reports indicate the original formula overestimates eGFR values, with the new adjusted equation including variables not measured for this cohort (cystatin C and blood urea nitrogen), and not yet validated in an SCD cohort (Selistre et al, 2016) ; while the CKD-EPI equation has been reported as the most appropriate for SCD populations (Arlet et al, 2012; Asnani et al, 2013) . The young age of the cohort is probably indicative of the severity and related low life expectancy of SCD patients in Cameroon, and the high prevalence of renal dysfunctions could be partly attributed to the associated poor health care system and the lack of a comprehensive programme for SCD, that is also accompanied with SCD being a great burden for Cameroonian families and patients (Wonkam et al, 2014a,c) . Future studies will need to investigate a prospective large cohort of adult SCD patients, in steady state.
Conclusion
The present study has revealed a high proportion of patients with micro-albuminuria (60Á9%; n = 248) and glomerular hyperfiltration (49Á5%; n = 200) among this group of patients living with SCD in Cameroon. Age, male sex, haemoglobin level, leucocyte count, MCV, mean blood pressure, systolic and diastolic blood pressure, BMI and creatinine levels significantly affected micro-albuminuria and/or eGFR. The study has confirmed that co-inheritance of alpha-thalassaemia is protective against macro-albuminuria, while APOL1G1/G2 risk variants are significantly associated with the ACR. This indicates a possible role of both APOL1 G1/ G2 and, possibly, HMOX1-rs743811 as useful biomarkers for risk assessment of renal dysfunctions in SCD.
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